ETON - Eton Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Deer Park,
United States
Type: Equity
ETON price evolution
ETON
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.69 | $16.66 | $21.39 | $22.07 |
| Short term investments | ||||
| Net receivables | $4.87 | $4.24 | $3.41 | $3.5 |
| Inventory | $2.07 | $2.32 | $0.91 | $1.05 |
| Total current assets | $25.43 | $24.26 | $26.84 | $27.16 |
| Long term investments | ||||
| Property, plant & equipment | $0.26 | $0.13 | $0.15 | $0.15 |
| Goodwill & intangible assets | $6.12 | $6.39 | $4.74 | $4.21 |
| Total noncurrent assets | $6.39 | $6.53 | $4.9 | $4.37 |
| Total investments | ||||
| Total assets | $31.82 | $30.79 | $31.74 | $31.53 |
| Current liabilities | ||||
| Accounts payable | $2.13 | $2.26 | $1.85 | $1.71 |
| Deferred revenue | ||||
| Short long term debt | $4.66 | $5.02 | $5.38 | $1.54 |
| Total current liabilities | $18.22 | $15.3 | $16.24 | $10.39 |
| Long term debt | $0.14 | $0.02 | $4.24 | |
| Total noncurrent liabilities | $0.14 | $0.02 | $4.24 | |
| Total debt | $4.8 | $5.02 | $5.4 | $5.78 |
| Total liabilities | $18.36 | $15.3 | $16.26 | $14.63 |
| Shareholders' equity | ||||
| Retained earnings | -$107.92 | -$104.88 | -$104.07 | -$101.81 |
| Other shareholder equity | ||||
| Total shareholder equity | $13.46 | $15.49 | $15.48 | $16.89 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $21.39 | $16.3 | $14.41 | $21.3 |
| Short term investments | ||||
| Net receivables | $3.41 | $1.85 | $5.47 | $0.05 |
| Inventory | $0.91 | $0.56 | $0.55 | $1.24 |
| Total current assets | $26.84 | $20 | $23.6 | $24.7 |
| Long term investments | ||||
| Property, plant & equipment | $0.15 | $0.26 | $0.22 | $1 |
| Goodwill & intangible assets | $4.74 | $4.75 | $3.62 | $0.57 |
| Total noncurrent assets | $4.9 | $5.03 | $3.86 | $1.62 |
| Total investments | ||||
| Total assets | $31.74 | $25.03 | $27.46 | $26.32 |
| Current liabilities | ||||
| Accounts payable | $1.85 | $1.69 | $1.77 | $2.34 |
| Deferred revenue | ||||
| Short long term debt | $5.38 | $1.03 | $1.42 | $0.28 |
| Total current liabilities | $16.24 | $6.46 | $4.56 | $3.79 |
| Long term debt | $0.02 | $5.38 | $5.28 | $6.86 |
| Total noncurrent liabilities | $0.02 | $5.49 | $5.28 | $6.86 |
| Total debt | $5.4 | $6.52 | $6.7 | $7.14 |
| Total liabilities | $16.26 | $11.95 | $9.84 | $10.66 |
| Shareholders' equity | ||||
| Retained earnings | -$104.07 | -$103.13 | -$94.11 | -$92.16 |
| Other shareholder equity | ||||
| Total shareholder equity | $15.48 | $13.08 | $17.63 | $15.66 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9.07 | $7.97 | $8.31 | $7.03 |
| Cost of revenue | $3.45 | $2.96 | $3.68 | $2.63 |
| Gross Profit | $5.63 | $5.01 | $4.63 | $4.4 |
| Operating activities | ||||
| Research & development | $2.97 | $0.65 | $1.05 | $0.61 |
| Selling, general & administrative | $5.59 | $5.16 | $4.58 | $4.34 |
| Total operating expenses | $8.56 | $5.81 | $5.62 | $4.95 |
| Operating income | -$2.94 | -$0.8 | -$0.99 | -$0.55 |
| Income from continuing operations | ||||
| EBIT | -$2.94 | -$0.8 | -$2.79 | -$0.55 |
| Income tax expense | $0.05 | $0.25 | ||
| Interest expense | $0.05 | $0.01 | -$0.78 | $0.03 |
| Net income | ||||
| Net income | -$3.04 | -$0.81 | -$2.26 | -$0.58 |
| Income (for common shares) | -$3.04 | -$0.81 | -$2.26 | -$0.58 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $32.64 | $22.89 | $23.33 | $0.04 |
| Cost of revenue | $10.58 | $6.93 | $2.62 | $0.29 |
| Gross Profit | $22.06 | $15.96 | $20.71 | -$0.25 |
| Operating activities | ||||
| Research & development | $3.32 | $4 | $6.24 | $14.1 |
| Selling, general & administrative | $18.93 | $18.58 | $14.47 | $12.76 |
| Total operating expenses | $22.25 | $22.58 | $20.7 | $26.86 |
| Operating income | -$0.19 | -$6.62 | $0.01 | -$27.11 |
| Income from continuing operations | ||||
| EBIT | -$1.19 | -$8.26 | -$0.95 | -$27.97 |
| Income tax expense | $0.25 | |||
| Interest expense | -$0.5 | $0.76 | $1.01 | |
| Net income | ||||
| Net income | -$0.94 | -$9.02 | -$1.96 | -$27.97 |
| Income (for common shares) | -$0.94 | -$9.02 | -$1.96 | -$27.97 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$3.04 | -$0.81 | -$2.26 | -$0.58 |
| Operating activities | ||||
| Depreciation | $0.3 | $0.25 | $0.28 | $0.2 |
| Business acquisitions & disposals | -$1.87 | |||
| Stock-based compensation | $0.84 | $0.82 | $0.75 | $0.73 |
| Total cash flows from operations | $1.25 | -$2.47 | $0.39 | $0.87 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | |||
| Investments | ||||
| Total cash flows from investing | -$1.88 | -$0.78 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.17 | $0.01 | -$0.09 | $0.02 |
| Net borrowings | -$0.39 | -$0.39 | -$0.39 | -$0.39 |
| Total cash flows from financing | -$0.22 | -$0.38 | -$0.29 | -$0.37 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.04 | -$4.73 | -$0.68 | $0.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$0.94 | -$9.02 | -$1.96 | -$27.97 |
| Operating activities | ||||
| Depreciation | $0.9 | $1.77 | $0.46 | $0.65 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.14 | $4.22 | $3.38 | $2.58 |
| Total cash flows from operations | $6.82 | $4.82 | -$4.72 | -$22.35 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | $0.69 | -$0.05 | |
| Investments | ||||
| Total cash flows from investing | -$0.78 | -$2.79 | -$2.56 | -$0.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.2 | $0.25 | $0.54 | $29.15 |
| Net borrowings | -$1.16 | -$0.39 | -$0.15 | $2.48 |
| Total cash flows from financing | -$0.96 | -$0.13 | $0.39 | $31.63 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.08 | $1.9 | -$6.89 | $9.23 |
News
Fundamentals
| Market cap | $276.77M |
|---|---|
| Enterprise value | $263.88M |
| Shares outstanding | 25.75M |
| Revenue | $32.38M |
|---|---|
| EBITDA | -$6.05M |
| EBIT | -$7.08M |
| Net Income | -$6.69M |
| Revenue Q/Q | -24.36% |
| Revenue Y/Y | 9.14% |
| P/E ratio | -41.39 |
|---|---|
| EV/Sales | 8.15 |
| EV/EBITDA | -43.62 |
| EV/EBIT | -37.29 |
| P/S ratio | 8.55 |
| P/B ratio | 20.56 |
| Book/Share | 0.52 |
| Cash/Share | 0.69 |
| EPS | -$0.26 |
|---|---|
| ROA | -21.25% |
| ROE | -43.62% |
| Debt/Equity | 1.05 |
|---|---|
| Net debt/EBITDA | -0.11 |
| Current ratio | 1.40 |
| Quick ratio | 1.28 |